FDA accepts TG Therapeutics' application for ublituximab + ukoniq in blood cancer
25 May 2021 - 9:20PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
TG Therapeutics (NASDAQ:TGTX)
Historical Stock Chart
From Apr 2024 to May 2024
TG Therapeutics (NASDAQ:TGTX)
Historical Stock Chart
From May 2023 to May 2024